A combination of stem cell and gene therapy is safe for humans and produces a protein that will protect motor neurons for those with amyotrophic lateral sclerosis, according to the first trial. Read the article to learn more.
Scientists are currently investigating the efficacy of a new oral drug candidate for Lou Gehrig’s disease treatment. Find out how effective this approach is.
A conscious person who is fully paralyzed was able to communicate in full sentences using only his thoughts. Read to know how this microchip brain implant helped him.
A new study suggests that the brain should be the primary target in treating amyotrophic lateral scoliosis (ALS) not the spinal cord, flipping a long-standing belief.
A team of scientists and engineers demonstrated a novel approach that could enable humans to control electronic gadgets - by inserting electrodes through the veins.
Researchers at the Jacksonville, Florida Mayo Clinic have gained a mouse model for testing potential amyotrophic lateral sclerosis (ALS) treatments. ALS or Lou Gehrig's disease is associated with various behavioral features and neuropathological symptoms as is frontotemporal dementia (FTD); both are caused by a mutation in the C9ORF72 gene. Both result in the death of neurons in the spinal cord and brain, which leads to inability to control muscles, paralysis, and death.